share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Jan 31 05:23
Summary by Moomoo AI
歌禮製藥有限公司於2024年1月31日提交了翌日披露報表，披露了自2023年12月19日至2024年1月31日期間的股份購回活動。根據報表，公司在此期間通過香港聯合交易所有限公司的主板上市規則進行了多次股份購回，但並未註銷這些股份。最後一次購回發生在2024年1月31日，當天購回了750,000股普通股，每股價格介於1.69港元至1.76港元之間，總計花費約1,293,920港元。自普通決議案通過以來，公司在香港交易所購回的股份總數達到61,621,000股，佔當時已發行股份的5.6682%。公司確認，所有購回活動均按照相關規則進行，並且已獲得董事會的正式授權批准。
歌禮製藥有限公司於2024年1月31日提交了翌日披露報表，披露了自2023年12月19日至2024年1月31日期間的股份購回活動。根據報表，公司在此期間通過香港聯合交易所有限公司的主板上市規則進行了多次股份購回，但並未註銷這些股份。最後一次購回發生在2024年1月31日，當天購回了750,000股普通股，每股價格介於1.69港元至1.76港元之間，總計花費約1,293,920港元。自普通決議案通過以來，公司在香港交易所購回的股份總數達到61,621,000股，佔當時已發行股份的5.6682%。公司確認，所有購回活動均按照相關規則進行，並且已獲得董事會的正式授權批准。
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on January 31, 2024, disclosing its share repurchase activities for the period from December 19, 2023 to January 31, 2024. According to the report, the company made several share repurchases during this period through the listing rules of the main board of the Hong Kong Stock Exchange Limited, but did not write them off. The last repurchase took place on 31 January 2024 and repurchased 750,000 shares of ordinary shares at a price of between HK$1.69 and HK$1.76 per share at a total cost of approximately HK$1,293,920. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the company on the HKEX reached 61,621,000 shares, representing 5.6682% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the relevant rules and have been formally authorized by the Board of Directors.
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on January 31, 2024, disclosing its share repurchase activities for the period from December 19, 2023 to January 31, 2024. According to the report, the company made several share repurchases during this period through the listing rules of the main board of the Hong Kong Stock Exchange Limited, but did not write them off. The last repurchase took place on 31 January 2024 and repurchased 750,000 shares of ordinary shares at a price of between HK$1.69 and HK$1.76 per share at a total cost of approximately HK$1,293,920. Since the adoption of the Ordinary Resolution, the total number of shares repurchased by the company on the HKEX reached 61,621,000 shares, representing 5.6682% of the shares issued at that time. The Company confirms that all repurchases are conducted in accordance with the relevant rules and have been formally authorized by the Board of Directors.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more